Thursday, February 01, 2024 9:54:30 PM
I must say Doc logic that I am somewhat confused about your opinion that the
SP is going to be crushed up to or even after MHRA approval? I also do expect the SP
to be increasingly suppressed up to approval and perhaps somewhat beyond approval
but I doubt that this can last for more than several months. What interests me to know
is your projected time as to how long the shorts and manipulators are likely to have the
upper hand and the reasons for your estimates.
Even without intervening post-approval positive events such as a partnership or a MTD denial,
the UK approval itself may have a very positive effect and that may start several months after approval
simply because of the increasing profits obtained from insured UK patients. The question then is for
how long can the shorts and manipulators retain their effectiveness in suppressing the SP.
SP is going to be crushed up to or even after MHRA approval? I also do expect the SP
to be increasingly suppressed up to approval and perhaps somewhat beyond approval
but I doubt that this can last for more than several months. What interests me to know
is your projected time as to how long the shorts and manipulators are likely to have the
upper hand and the reasons for your estimates.
Even without intervening post-approval positive events such as a partnership or a MTD denial,
the UK approval itself may have a very positive effect and that may start several months after approval
simply because of the increasing profits obtained from insured UK patients. The question then is for
how long can the shorts and manipulators retain their effectiveness in suppressing the SP.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
